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Introduction 
Hematopoietic stem and progenitor cells (HSPC) nor-
mally reside in the bone marrow (BM), however in
physiological conditions, very low number of early
hematopoietic stem cells circulate in the peripheral
blood. The number of the cells in blood can increase
during pharmacologic mobilization, which has been
shown to be induced clinically or experimentally in
animal models by a wide number of molecules includ-
ing cytoreductive drugs, such as cyclophosphamide
(CY) [1,2]. Cyclophosphamide, a DNA alkylating
agent, is widely exploited in cancer chemotherapy.
However, this cytoreductive chemotherapeutic agent
can be used alone or in combination, mainly with G-
CSF, to mobilize HSPC from the BM compartment.
Both CY and G-CSF induce the expansion of neu-
trophils and their progenitors within the BM [3]. The
mechanism of HSPC mobilization with chemothera-
peutic alone or in combination with e.g. G-CSF
induces accumulation of proteases released from neu-
trophils into the extravascular compartment of BM.
These proteases degrade and inactivate adhesive and
chemotactic interactions between HSPC and the BM
stromal cells, particularly VCAM-1, CXCR4 and its
ligand SDF-1, decreasing affinity of CXCR4/SDF-1
axis [3-7]. A pivotal role in the mobilization of HSPC
is attributed to complement system and egress of
HSPC from the BM is thought as a part of an immune
response [8]. 
Nevertheless, the morphology of the bone marrow
and organs which could be repopulated by mobilized
HSPC is poor known. In our previous studies we
observed in mice morphological changes in organs
participating in hematopoiesis during mobilization
with G-CSF alone and G-CSF plus CY [9-11]. Our
preliminary study had shown drastic changes in BM
morphology on the 2nd day after single injection of CY
and the changes were maintained until the 4th day of
experiment [12]. The aim of the present study was to
show the morphology and ultrastructure of the bone
marrow, spleen and liver of mice after one-off admin-
istration of cyclophosphamide as well as the localiza-
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tion of cells expressing markers of early hematopoiet-
ic cells in studied organs. 
Material and methods 
Mice. The experiment was performed on pathogen-free, 5-week-
old, mature female inbred Balb C mice (Polish Academy of
Sciences, Wroclaw, Poland). The animals were maintained under
standard laboratory conditions in a 12hr/12hr light-dark cycle at
21°C. An approval from Local Ethical Committee was obtained.
The animals were randomly divided into control and experimental
groups (10 animals in each group). The mice of experimental
group were injected intraperitoneally with single dose (200 mg/kg
bw) of cyclophosphamide (Endoxan, Asta Medica) on the day 0. of
the experiment. Cyclophosphamide (CY) was diluted in solution of
saline, according to the manufacture's recommendation. The mice
of control group were injected intraperitoneally with a phosphate-
buffered saline (PBS) on the day 0 in the same volume as the
cyclophosphamide in experimental group. The experiment was ter-
minated after 6 days. The mice of control and experimental groups
were sacrificed by lethal anesthesia with 90 mg/kg bw thiopental
(Biochemie GmbH, Kundl, Austria) after 2, 4 and 6 days of the
experiment. Fragments of spleen and liver were collected and fixed
with Carnoy'a solution [13]. Femurs were decalcified and embed-
ded in paraffin. For morphological studies, the slides were stained
with H-E, H+E slides of liver with PAS method, and additionally
the silver impregnated method was used to visualize of reticular
fibers in the spleen [13]. Pieces of spleen and liver for immunos-
taining were fixed in 4% formaldehyde freshly prepared from
paraformaldehyde and embedded in paraffin.  
Transmission electron microscopy [TEM]. For electron micro-
scopic studies, the bone marrow of control and experimental mice
was obtained (flushed from the femurs) using syringe and Iscove's
medium. Bone marrows were fixed in 0.25 M glutaraldehyde in 0.1
M cacodylate buffer pH=7.4 for 2 hr at 4°C, post-fixed in 0.04 M
OsO4, and dehydrated in ethyl alcohol (30-96%) and 100% ace-
tone, subsequently embedded in a Spurr low-viscosity embedding
kit (Polysciences, Inc. Warrington, PA). Ultrathin sections were
prepared with Reichert OmU2 ultramicrotome, contrasted with
uranyl acetate and lead citrate, and analyzed in a JEM-1200 EX
transmission electron microscope at 80 kV. 
Immunohistochemical staining. Immunohistochemical reactions
for identification of early hematopoietic stem cells in specimens of
bone marrow, spleen and liver were performed using following
antibodies: 
• rabbit polyclonal anti-Thy-1 (H-110) (Santa Cruz Biotechnol-
ogy, Inc., USA); – antibody raised against recombinant protein
corresponding to amino acids 20-130 representing the mature
Thy-1 of human origin. Thy-1 (H-110) reacts with Thy-1 of
mouse, rat and human origin. 
• rabbit polyclonal anti-c-Kit (C-19) (Santa Cruz Biotechnology,
Inc., USA) – antibody against peptide mapping within the car-
boxy terminal domain of c-Kit p145 of human origin. The lig-
and for c-Kit receptor has been identified and shown to be
encoded at the murine steel (SI) locus. 
Briefly, specimens were cut in 5 μm sections, mounted on
poly-L-lysine-coated microscope slides, deparaffinized, rinsed
with graded alcohol, and washed with water. To reduce non-spe-
cific staining, the slides were immersed in 3% hydrogen peroxide
for 30 min at room temperature to quench endogenous peroxidase
activity. After washing in Tris-buffered saline (TBS) twice for 5
min, sections were submerged in 10 nM citric buffer, pH=6.0, and
microwaved at high power two times for 5 min each time. Slides
were then left to cool to room temperature in the buffer solution
(20 min). Slides were washed again in TBS twice for 5 min, and
non-specific binding was blocked by incubation with 3% normal
goat serum for 30 min at room temperature followed by incubation
with primary antibodies: anti-Thy-1 antibody (1:500) or anti-c-Kit-
R antibody (1:200) for the time recommended in the manufacturer
s protocol at 22°C. Slides were subsequently washed twice with
TBS for 5 min and incubated with biotinylated anti-
rabbit/mouse/goat immunoglobulins [(LSAB+AP Link, Universal,
DAKO, Carpinteria, USA]. Sections were washed in TBS and
incubated for 30 min with streptovidin conjugated to alkaline phos-
phatase (AP) (DAKO, Corporation, Carpinteria, USA). Sites indi-
cating antibody binding were visualized using Fuchsin+chro-
mogen (DAKO LSAB®+SYSTEM, AP) and fuchsia-coloured end
product was obtained. Sections were washed in TBS and incubat-
ed counterstained with Mayer hematoxylin. Control slides were
incubated without the primary antibody. 
Flow cytometry. On the days 2, 4, and 6 after CY injection periph-
eral blood was obtained in each case from vena cava (with a 25-
guage needle and 1 mL syringe containing 250 U heparin) and
enriched for light-density mononuclear cells as described previ-
ously [14]. To determine the amount of c-Kit-R-positive cells, flow
cytometric analysis was performed. Briefly, 50 μL whole blood
was stained with rat anti-mouse c-Kit-R fluorescein isothiocyanate
(FITC)-conjugated monoclonal antibody (final concentration 1
μg/mL; BD Biosciences Pharmingen, San Diego, CA, USA). Sam-
ples stained with appropriate isotype controls (BD Biosciences
Pharmingen) were also examined. After 20-min incubation on ice,
2 mL of FACS lysing solution (BD Biosciences Immunocytometry
System, USA) was added to lyse the erythrocytes. The cells were
washed twice in PBS, resuspended in 0.3 mL PBS, and analyzed
by FACScan using CELLQUEST v.3.1 software (BD Biosciences
Immunocytometry System, USA). Typically, 20 000 events were
acquired  and the percentage of c-Kit-R-positive cells were deter-
mined for the whole leukocyte population.  
Statistical analysis. Arithmetic mean and the standard deviation
(mean ± SD) data were determined using the STATGRAPHICS
v.5.0. package (Manugistic Inc., Rockville, MD, USA). Statistical
significance was defined as P<0.05. Data were analysed using Stu-
dent's t-test for unpaired samples. 
Results 
Bone marrow morphology during hematopoietic
cell mobilization with CY in mice
Control mice. As it was presented in our former study
[12], in the bone marrow of control mice hematopoietic
cells arranged in hematopoietic cords were observed.
Among the hematopoietic cells megakaryocytes with an
irregularly lobulated nucleus were spread. The lumen of
sinusoidal capillaries was filled with single leukocytes.
Adipose cells were not visible (Fig. 1A). 
Experimental group of mice. After two days of mobi-
lization with CY, the structure of the bone marrow was
severely damaged. The vascular compartment of bone
marrow with dilated sinusoids filled with erytrocytes
dominated over the hematopoietic compartment. There
were only little islets of hematopoietic cells.
Megakaryocytes and erythrocytes outside capillaries
were seen among hematopoietic cells. Few cells con-
taining hemosiderin were visible in hematopoietic
compartment (Fig. 1B). 
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After 4 days of mobilization with CY, the sinusoids
of the bone marrow were distinctly dilated but the area
occupied by hematopoietic cells increased and numer-
ous proliferating cells were observed within the
hematopoietic compartment. There were numerous
hemosiderin granules within both hematopoietic and
vascular compartments (Fig. 1C). 
After 6 days of mobilization with CY the morphol-
ogy of the BM was similar to that observed in control
mice. However, the amount of hematopoieic cells was
increased and proliferating cells were visible. The
lumens of sinusoid were still insignificantly dilated
and single leucocytes were inside present. 
The ultrastructure of the bone marrow 
The BM ultrastructure of control mice was the same as
that observed in mice stimulated with G-CSF [10] and
G-CSF plus CY [11]. Briefly, sinusoids of the BM pre-
sented a normal structure. The wall of capillaries was
composed of a single layer of fenestrated endothelial
cells resting on the discontinuous basal lamina (not
shown). 
After day 2. of mobilization with CY the structure
of the bone marrow was damaged and signs of fibrosis
were observed. Numerous collagen fibers were accu-
mulated in the stroma (Fig. 2A). 
After 4 days of the experiment ultrastructure of the
bone marrow was formerly changed. Beside of
increased number of hematopoietic cells, the features
of fibrosis were still observed. However, the amount of
collagen fibers decreased (Fig. 2B). 
After 6 days of mobilization with CY the ultra-
structure of the bone marrow approximated the tissue
of control mice. However, evidently wide spaces
between the endothelial cells of sinusoids and cells
traversing the endothelial wall were visible, similar
to those visible in the BM of mice stimulated with G-
CSF plus CY [11]. 
Immunolocalization of early hematopoietic cells
in the bone marrow of control mice 
The colored product of immunohistochemical reaction
was found in the cytoplasm of the BM cells. There was
no reaction in the nuclei of the cells. The localization
of cells that were identified with two different anti-
bodies (anti-c-Kit-R and anti-Thy-1) in other slides,
was the same. Few cells displayed c-kit-R- or Thy-1-
positive reaction among hematopoietic cells.  
Spleen morphology during hematopoietic cell
mobilization with cyclophosphamide in mice
Control mice. Splenic pulp of control mice was com-
posed of white pulp and red pulp. White pulp con-
sisted of lymphoid nodules with the central artery
located eccentrically. Lymphoid nodules appeared
within the red pulp were surrounded with well visible
marginal zone (Fig. 3A). Red pulp was composed of
elongated splenic cords and sinusoids lying between
cells of the splenic cord. Megakaryocytes with an
irregularly lobulated nucleus were visible among the
cells of red pulp. 
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Fig. 1. The bone marrow of control (A) and CY-mobilized mice (B, C). The strong dilated sinusoids filled with erythrocytes, and the pres-
ence the erythrocytes among cells of small areas of hematopoietic compartment in BM after 2 days of experiment (B). The increase in
hematopoietic cells number with the proliferating cells, and cells with hemosiderin, both in hematopoietic and vascular compartments on
the 4th day (C) H+E. 
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Fig. 2. Ultrastructure of the bone marrow of
mice mobilized with CY. Symptoms of
fibrosis with deposits of collagen fibers
(arrow) in the BM on the 2nd (A) and 4th (B)
days. TEM.
Fig. 3. Morphology of spleen in
control mice and after CY mobiliza-
tion. The white pulp (WP) and the
red pulp (RP) in spleen of control
mice (A), and domination of RP
over WP in the spleen of mice on
the 2nd day of experiment H+E.
Experimental group of mice. On the 2nd day after
injection of mice with CY, the spleen displayed
increase in red pulp area over white pulp and
decrease in size of lymphoid nodules. The marginal
zone around lymphoid nodules and splenic cords in
the red pulp were poorly visible. Sinusoids were
filled with erytrocytes. There were megakaryocytes
with strongly stained nuclei. Single cells with gran-
ules of hemosiderin were observed (Fig. 3B). 
In macroscopic observation, the size of spleen in
mice on the day 4. of experiment was significantly
lower than the size of control mice spleen. The far-
ther continuation decrease in volume of white pulp
was observed. The lumen of trabecular vessels was
considerably dilated and filled mainly with erytro-
cytes. Single megakaryocytes and numerous cells
with hemosiderin granules were visible in red pulp.
The morphology of spleen in mice after the day 6.
since the injection with CY was similar to that
observed in control mice. However, the lumen of
parenchymal vessels was insignificantly dilated and
filled with numerous of leukocytes. 
The visualization of reticular fibers 
After silver impregnation of specimens of spleen in
control mice, the network of reticular fibers was visi-
ble (Fig. 4A). A prominent densification of reticular
fibers was observed on the 2nd and 4th day of experi-
ment (Fig. 4B,C), while the reticular network in spleen
in the experimental mice on day 6 seemed to be simi-
lar to the control. 
Immunolocalization of early hematopoietic cells
in spleen 
The identification of early hematopoietic cells in
spleen of control and experimental groups of mice
were carried out with two different antibodies but the
localization of stained cells was the same for both
antibodies. The product of immunohistochemical
reactions was seen only in the cytoplasm of cells. In
the spleen of control group of mice single Thy-1- or
c-Kit-R-positive were present within the white pulp
and red pulp (Fig. 5A). The increase in number of
immunopositive cells was found in spleen of mice on
the 6. day of the experiment. The cells were located
both in white and red pulp of spleen (Fig. 5B). 
Liver morphology during hematopoietic cell
mobilization with CY in mice
Control mice. The classic liver lobules were not
markedly separated from each other by connective
tissue. At the corner of the lobules the portal spaces
were present, occupied by the portal vein, the hepat-
ic artery and the bile duct as well as small amount of
connective tissue. Hepatocytes were grouped in
interconnected plates. The radial dispositions of the
plates forming a layer one or two cell thick layer
were visible in the lobule. These plates were direct-
ed from periphery of the lobule to its center where
the centrolobular vein was present. The plates of
hepatocytes were separated by sinusoidal capillar-
ies. In the lumen of the sinusoid the nuclei of Kupf-
fer cells were seen. The cytoplasm of hepatocytes
stained with H-E was eosinophilic and contained
one or two nuclei with granular chromatin (not
shown). 
Experimental group of mice. There were no dis-
tinct changes in morphology of liver of experimen-
tal group of mice. However, on the day 6. of the
experiment the increase of lymphoid tissue elements
and number of Kupffer cells were observed (not
shown). 
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Fig. 4. Distribution of reticular fibers in the spleen of control mice (A) and mice on 2nd (B) and 4th (C) day after CY treatment.
Immunolocalization of Thy-1- or 
c-Kit-R-positive cells in liver 
Three types of cells showing Thy-1 or c-Kit-R expres-
sion were observed in liver of control and experimen-
tal group of mice. There were small cells located in
portal space as well as among hepatocytes and cells
resemble two nuclei hepatocytes. These data are in
accordance with those observed in our previous study
[11]. 
Percentage of c-Kit-R-positive cells in peripher-
al blood 
We found the increase in number of circulating c-Kit-
R-positive cells with peak number on day 6 of the
experiment (Fig. 6). However, this increase was statis-
tically insignificant. 
Discussion 
Hematopoietic stem and progenitor cells (HSPC) nor-
mally reside in the BM. They are confined to the bone
marrow niches, proliferate and following differentia-
tion, as mature blood cells migrate into the circulation.
However, small pool of primitive stem cells continu-
ously circulates in blood [15]. The circulating fraction
of these cells can be increased by process named mobi-
lization. The pharmacological mobilization of
hematopoietic stem and progenitor cells is usually
obtained by using cyclophosphamide in combination
with myeloid growth factors, which enhance the effect
of chemotherapeutic agent [3,5,6,16]. Although the
molecular mechanism of mobilization is widely exam-
ined, the morphology of the bone marrow and organs,
which participate in hematopoiesis in mice, is poorly
known. In our study, the morphology and ultrastruc-
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Fig. 5. Immunolocalization of c-Kit-R-pos-
itive cells in the spleen. The individual
immunopositive cells in the spleen of con-
trol mice (arrow) (A) and numerous cells
with immunostaining in spleen of mice on
the 4th and 6th day after CY treatment. 
ture of the bone marrow, morphology of the spleen and
liver on day 2., 4., 6. after mobilization with
cyclophosphamide in murine model were examined. 
It has been known that CY induces the BM aplasia,
and we also observed typical morphological features
of this process. On the 2nd day after mobilization with
single dose of CY we noticed destructive changes in
the bone marrow [12]. The dramatic reduction in
hematopoietic area and increased vascular compart-
ment with strongly dilated sinusoids were observed as
the effect of cytoreductive properties of cyclophos-
phamide. There were cells containing hemosiderin
among the hematopoietic cells, what indicated the
phagocytosis performed by stromal cells and
macrophages removing the damaged cells. The erythro-
cytes are normally confined to the vascular space, thus
their presence within the hematopoietic compartment
suggested the loss of integrity of sinusoidal wall. Lack
of sinusoid continuity supported the observation of pen-
etration of macrophages into the lumen of vessel. The
findings were in accordance with studies of other
authors [17,18]. Additionally, we found the features of
fibrosis in ultrastructure of the BM. It could be the
response of stromal cells to changes of the bone marrow
microenvironment and impaired interaction between
bone marrow cells and extracellular matrix elements. 
Myelofibrosis is common clinical feature in a vari-
ety of hematological malignancies [19,20]. This
includes the synthesis and local collagen deposition.
The molecular basis of the process is unknown but it
seems to be multifactoral [21]. In vivo and in vitro stud-
ies indicate that several cytokines are involved in the
development of myelofibrosis [22,23]. TGF-β1, secret-
ed by megakaryocytes and platelets [24,25] is consid-
ered to play the crucial role in the development of
myelofibrosis. This pleiotropic cytokine stimulates stro-
mal cells of the BM to produce collagen and other extra-
cellular matrix proteins [22,26]. Moreover, TGF-βmod-
ulates extracellular matrix organization and stimulates
the expression of proteases, which inhibit the enzymes
involved in degradation of matrix proteins [27]. 
On day 4. of the experiment the proliferating cells
and the increase of hematopoietic cell amount were
observed within the hematopoietic compartment. It
was reported by others, that CY administration led to a
rapid decrease in nucleated cells number [28,29] on
the 2nd day and the intensive proliferation of cells in
the bone marrow on days 2-3 [29]. At that time the
expression pattern of cytokine genes was changed in
the bone marrow. While, the level of mRNA for TGF -
1 was decreased, the levels of mRNA for SCF and
SDF-1 were increased [30], what supposedly support-
ed proliferation of the hematopoietic cells. Deposits of
collagen were still observed, however its amount was
diminished. 
The bone marrow cellularity returned to normal
values on the day 6. of the experiment. This result was
in accordance with observation of Sefc et al. [29]. The
ultrastructure of the bone marrow was normal but the
distances between endothelial cells of sinusoids were
extended, what facilitated the departure of HSPCs
from the BM. The presence of numerous nucleated
cells in lumen of sinusoids visible under light
microscopy may suggest that early hematopoietic cells
left the bone marrow. We found, that the number of c-
Kit-R-positive cells in the peripheral blood has peaked
on the 6th day of the experiment. The study by Crad-
dock et al. [31] reported that peak numbers of CFU-S
and CFU-GM in the peripheral blood occurred 8 days
after cyclophosphamide administration. In our previ-
ous studies, the biggest pool of c-Kit-R-positive cells
in the circulation was observed on the 4th day during
treatment with G-CSF [10] and G-CSF plus CY [11].
Had our experiment been carried out longer, the c-Kit-
R-positive cells would have occurred in higher per-
centage in following days.
The spleen of mice treated with CY revealed
changes in morphology including a hyperplasia of the
red pulp. The spleen in mice is an active hematopoiet-
ic organ during the ontogenesis [32]. Similarly to the
bone marrow, cyclophosphamide caused cytoreductive
effect in spleen. Moreover, in our observation CY pro-
duced temporary fibrosis of spleen   deposits of retic-
ulin were seen on the day 2., less visible on day 4. and
the normal amounts were observed back on day 6. of
the experiment. It was shown, that administration of
CY was associated with marked cytopenia in the
spleen [33] and directly induced a significant decrease
in number of the myeloid progenitors [34]. On day 4.,
we observed the reduction of spleen mass, what was in
accordance with the discovery by Karp & Szczytkows-
ki [35]. This effect can be related to severe leukopenia,
with was deepest on day 4. after injection with CY, as
reported by Shalit et al. [34]. The increase of the
amount of the cells between day 4. and 6. can be
explained in two ways: the proliferation of cells in the
spleen and the transfer of hematopoietic stem and pro-
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Fig. 6. Percentage of c-Kit-R-positive cells in MNC of control and
experimental group of mice. 
genitor cells from the bone marrow. During mobiliza-
tion of mice with CY, the pattern of hematopoietic
cytokine expressions in spleen was changed, as it was
seen in the BM. The level of SCF mRNA was about
50-fold higher in the spleen when compared to the
bone marrow [29]. It was shown, that the CFU-S dou-
bling time in the spleen was 4.4 h between days 4 and
5 after administration of cyclophosphamide, thus it
would not be able to significantly contribute to the
obtained results by proliferation and self-reproduction
of cells alone. Therefore a significant migration of pro-
genitors from the bone marrow to the spleen has been
expected to be responsible for the observed effects
[29].
On the day 6. the cellularity in the spleens of exper-
imental mice appeared to be similar to the spleens of
control mice, and the number of proliferating cells
observed in the spleen was decreased. As it was report-
ed, the CFU-S proliferation rate in spleen decreased on
days 8. and 9. after CY mobilization [29], and our pre-
vious study presented the decrease in the proliferating
cells number in spleen on day 6. after G-CSF plus CY
treatment [11]. There were no features of fibrosis in
the spleens of experimental mice on day 6. The mech-
anism of the spleen fibrosis is the same as in the BM
and it is related to the increase in TGF-β1, produced by
megakaryocytes. The densification of the reticulin net-
work was observed in the spleens of mice with throm-
bopoietin overexpression [22,36]. 
There were no marked morphological changes in
the livers of experimental mice. Although cyclophos-
phamide is regarded to be a hepatotoxic agent, the
hepatocytes' morphology observed in light microscopy
was not altered. However, Malhi et al. [37] showed in
electron microscopy experiments the endothelial
injury just within 6 hours after CY treatment and the
endothelium disorganization in most sinusoids was
observed after 24 and 48 hours. In their studies, CY
had no obvious effects on hepatocytes and Kupffers'
cells [37]. In our experiment, we observed the increase
in number of Kupffers' cells in zone III (central venous
drainage) and zone II (intermediate region) on day 6.
after CY administration. Hyperplasia of Kupffers' cells
can reflect the activity of hepatic lymphoid tissue.
Alongside with hepatic macrophages, the liver con-
tains other components of lymphoid tissue such as T
lymphocytes, B cells, NK cells [38]. In response to
toxic factors, the hyperplasia of lymphoid tissue com-
ponents can be observed. The localization and shape of
Thy-1- or c-Kit-R-positive cells in liver of mice were
the same as in our earlier study [11]. 
Finally, we conclude that mobilization HSPC with
cyclophosphamide alone in mice results in the aplasia
of the BM with features of myelofibrosis and morpho-
logical alteration of the spleen and no pronounced
changes in the liver, as examined under light micro-
scope. The beginning of the recovery of the BM ultra-
structure was observed on the 6th day after CY injec-
tion. The egress of HSPC from the BM was also
observed on the 6th day, and it was the time of repop-
ulation of spleen with these cells. However, the release
of HSPC from the bone marrow into the peripheral
blood was delayed as compared to mice treated with
G-CSF or GCS-F plus CY. 
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